adult acute lymphocytic leukemia Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Chinese University of Hong Kong (1)

No (1)

No (1)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadleukemia

I am/have/hadacute lymphoblastic leukemia

I am/have/hadb-cell acute lymphoblastic leukemia

I am/have/hadremission

I am/have/hadflow cytometry

I am/have/hadcns involvement

I am/have/hadtesticular

I am/have/hadleukemic cells

I am/have/hadhematopoietic stem cell transplantation

added new label for I am/have/had

more

I am looking for

I am looking forpediatric

I am looking forbortezomib injection

I am looking forproteasome inhibitor

I am looking forrituximab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For pediatric ages
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Study of adding anti-CD20 antibody (rituximab) with chemotherapy: CD20 is found to be expressed in 40-50% of B-lineage ALL, and rituximab has been studied in adult ALL with superior survival (75% vs 47%,). There is little experience of using rituximab in pediatric ALL thus a CCCG Relapsed ALL 2017 Study …

flow cytometry

remission

acute lymphoblastic leukemia

rituximab

testicular

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.